Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Pseudomonas aeruginosa in Cystic Fibrosis Patients With G551D-CFTR Treated With Ivacaftor

2014; Oxford University Press; Volume: 60; Issue: 5 Linguagem: Inglês

10.1093/cid/ciu944

ISSN

1537-6591

Autores

Sonya L. Heltshe, Nicole Mayer-Hamblett, Jane L. Burns, Umer Khan, Arthur Baines, Bonnie W. Ramsey, Steven M. Rowe,

Tópico(s)

Respiratory viral infections research

Resumo

Background. Ivacaftor improves outcomes in cystic fibrosis (CF) patients with the G551D mutation; however, effects on respiratory microbiology are largely unknown. This study examines changes in CF respiratory pathogens with ivacaftor and correlates them with baseline characteristics and clinical response.

Referência(s)